Poster Presentations: Late-Breaking Poster: In addition, William Audeh, MD, MS, Chief Medical Officer of Agendia, will be ...

Illumina (ILMN) will release TruSight Oncology 500 v2, a new version of its flagship cancer research assay to enable comprehensive genomic ...

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, will present 10 abstracts demonstrating the breadth of its Precision Oncology portfolio at the 2024 ...

These DQ treats once believed to be universally adored have ended up on the long-lost menu of items the chain is probably ...

The summit kicked off with 34 posters featuring the diversity of Hub-funded research. The posters focused on the Hub’s four ...

Illumina raised the curtain on a revamp of its flagship tumor profiling test, which aims to offer faster turnarounds, fewer ...

Illumina to release new version of its flagship cancer research assay, TruSight Oncology 500 v2: San Diego Thursday, November 21, 2024, 16:00 Hrs [IST] Illumina, Inc., a global le ...

For three days, a section of Kenyans experienced a Russian atmosphere during the Days of Russian Language and Culture event held at the Sarit Centre. Participants explored Russia's rich heritage ...

Researchers exploring the mating behaviors of Brazil's endangered northern muriquis have utilized fecal DNA analysis to ...

Studies investigating what is damaging the kidney in lupus nephritis point to tubulointerstitial inflammation.

HemoSonics, LLC, a medical device company focused on acute bleeding management, today announced it ranks #453 on the Deloitte Technology Fast 500tm, a ranking of the 500 fastest-growing technology, ...

Improved outcomes were seen with magrolimab plus docetaxel in patients with metastatic non-small cell lung cancer (NSCLC) who had higher CD47 expressions, according to a presentation on ... “Despite a ...